Date: 2011-11-16
Type of information: Grant
Company: Arcarios (The Netherlands)
Investors: Flemish agency for Innovation by Science and Technology (IWT) (Belgium)
Amount: €920K
Funding type: grant
Planned used: The grant will initially cover a period of 18 months and supports two of Arcarios\' programs: ARC-205 for cancer treatment-induced osteoporosis, and its next-generation TGF-beta modulator that promotes cartilage formation in osteoarthritis.
Others: Arcarios will perform this work in close collaboration with a group of renowned scientists in the field of anabolic bone growth: Prof. Peter ten Dijke (Leiden UMC, The Netherlands), Prof. Hans van Leeuwen (Erasmus MC, The Netherlands), Prof. Rik Lories and Prof. Frank Luyten (both K.U. Leuven, Belgium). In collaboration with its Project Partners, Arcarios expects to reach some major value inflection points: Finalize pre-clinical work on ARC-205; Develop a lead molecule from the TGF-beta modulator program; and File new IP.
Therapeutic area:
